compounded semaglutide crackdown news october 2025 September 2, 2025: U.S. compounding restrictions have stemmed a flood of and tirzepatide – Partnership for Safe Medicines FDA is moving to restrict

Generally, compounding of FDA-approved drugs is restricted to patient-specific prescriptions from licensed compounding pharmacies, not bulk manufacturing

A Western manufacturer imports many of the same raw materials from, you guessed it, China

During this process, your healthcare provider reviews your current medications, previous weight loss efforts, and any chronic conditions such as diabetes, hypertension, or thyroid disorders

The full therapeutic benefit of retatrutide is generally observed at higher maintenance doses, which are reached gradually over several weeks or months

Albumin-based drug designs for pharmacokinetic modulation

Retatrutide targets three hormone receptors simultaneously (GLP-1, GIP, and glucagon), distinguishing it from approved agents such as semaglutide (GLP-1 agonist) and tirzepatide (dual GIP/GLP-1 agonist)